title: Ceftazidime in patients with impaired renal function. Studies on pharmacokinetics and nephrotoxicity.
authors.affiliation: Department of Pharmacology and Toxicology, Faculty of Medicine, University of Trondheim, Trondheim, Norway.
authors.forename: E
authors.initials: E
authors.lastname: Thurmann-Nielsen
authors.forename: R A
authors.initials: RA
authors.lastname: Walstad
authors.forename: K
authors.initials: K
authors.lastname: Dahl
authors.forename: K B
authors.initials: KB
authors.lastname: Hellum
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics / Q000633:toxicity; D002442:Ceftazidime / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000633:toxicity; D003404:Creatinine / Q000378:metabolism; D005260:Female; D006207:Half-Life; D006801:Humans; D007275:Injections, Intravenous; D007668:Kidney / Q000187:drug effects* / Q000473:pathology; D007674:Kidney Diseases / Q000378:metabolism*; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D014552:Urinary Tract Infections / Q000097:blood / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D002442:Ceftazidime; D003404:Creatinine